Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy; Phase I Multicenter Study to Assess Treatment Feasibility and Safety

NCT05620199 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT05620199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy; Phase I Multicenter Study to Assess Treatment Feasibility and Safety
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2023
Completion date
April 1, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cavitation lung, chemoradiotherapy, feasibility, locally advanced non-small cell lung cancer, safety, surgery